LEUCEMIA PROMIELOCÍTICA AGUDA (LPA): DETECCIÓN DE TRANSLOCACIÓN t(15;17)(q24;q21) - CIDEGEN
CIDEGEN
Delivery time
<1 week
Sample
Blood. Biopsy tissue. Bone marrow
167,00€
A characteristic alteration of Acute Promyelocytic Leukemia (present in more than 90% of cases). Generally characterized by the t(15;17) translocation that generates the PML::RARA fusion gene. Depending on the breakpoint in PML, different transcripts are distinguished, the most frequent being bcr1, bcr2, and bcr3. Treatment with ATRA and ATO.
Other tests
LEUCEMIA LINFOBLÁSTICA AGUDA (LLA): DETECCIÓN DE TRANSLOCACIÓN t(12;21)(p13;q22) - CIDEGEN
166,98€
PEDIATRIC CANCER: CLINICAL EXOME PANEL (Sec. & CNVs) – 168 genes
850,00€
LEUCEMIA MIELOIDE CRÓNICA (LMC): DETECCIÓN DE TRANSLOCACIÓN t(9;22)(q34;q11) - CIDEGEN
167,00€